Eye Diseases, Hereditary Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
- Leber Congenital Amaurosis (LCA)
- +3 more
- AAV OPTIRPE65
- Ann Arbor, Michigan
- +1 more
2022-04-07
Apr 7, 2022E
Recruiting
- Blindness
- +7 more
- Miami, Florida
- +4 more
2022-03-30
Mar 30, 2022P
Active, not recruiting
- Leber Congenital Amaurosis 10
- +9 more
- sepofarsen
- Sham
- Iowa City, Iowa
- +13 more
2022-03-02
Mar 2, 2022P
Recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure
- Dallas, Texas
- +2 more
2022-02-22
Feb 22, 2022P
Recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure
- Dallas, Texas
- +2 more
2022-02-22
Feb 22, 2022N
Efficacy and Safety of of vMCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
- Beverly Hills, California
- +6 more
2022-02-18
Feb 18, 2022E
Recruiting
- Blindness
- +7 more
- Miami, Florida
- +6 more
2022-01-31
Jan 31, 2022P
Active, not recruiting
- Leber Congenital Amaurosis 10
- +9 more
- Iowa City, Iowa
- +2 more
2022-02-08
Feb 8, 2022J
Recruiting
- Retinal Degeneration
- +2 more
- San Francisco, California
- +7 more
2022-01-12
Jan 12, 2022S
Recruiting
- Graves Ophthalmopathy
- +8 more
- Doxycycline hyclate
- Placebo
- Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
2021-11-16
Nov 16, 2021P
Active, not recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure (dose cohort 1&2 only)
- Boston, Massachusetts
- +6 more
2021-09-14
Sep 14, 2021P
Recruiting
- Autosomal Dominant Retinitis Pigmentosa
- +7 more
- QR-1123
- Sham procedure
- Aurora, Colorado
- +4 more
2021-05-17
May 17, 2021S
Completed
- Graves Ophthalmopathy
- +8 more
- Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
2013-12-07
Dec 7, 2013H
Completed
- Eye Diseases, Hereditary
- (no location specified)
2008-12-18
Dec 18, 2008